Prednisolone Clinical Trials
17 actively recruiting trials across 6 locations
Also known as: (11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione, .delta.1-Hydrocortisone, 15 mg/mL oral solution National Drug Code: 0121-0885-08, Adnisolone, Aprednislon, Capsoid, Cortalone, Corticosteroids, Cortisolone, Dacortin H, Decaprednil, Decortin H, Delta(1)Hydrocortisone, Delta- Cortef, Delta-Cortef, Delta-Diona, Delta-F, Delta-Phoricol, Delta1-dehydro-hydrocortisone, Deltacortril, Deltahydrocortisone, Deltasolone, Deltidrosol, Dhasolone, Di-Adreson-F, Dontisolon D, Estilsona, Fisopred, Frisolona, Gupisone, Hostacortin H, Hydeltra, Hydeltrasol, Klismacort, Kuhlprednon, Lenisolone, Lepi-Cortinolo, Linola-H N, Linola-H-Fett N, Longiprednil, Metacortandralone, Meti Derm, Meticortelone, Opredsone, Panafcortelone, Pevanti, Precortisyl, Pred, Pred-Clysma, Predeltilone, Predni-Coelin, Predni-Helvacort, Prednicortelone, Prednisolonum, Prednisone, Prelone, Prenilone, Sterane
Other8 trials
Birmingham, Alabama4 trials
Children's Hospital of Alabama
Children's Hospital of Alabama
Mobile, Alabama1 trial
Gilbert, Arizona1 trial
Banner MD Anderson Cancer Center ( Site 0165)
Tucson, Arizona1 trial
Los Angeles, California1 trial
Children's Hospital Los Angeles
Tampa, Florida1 trial
H. Lee Moffitt Cancer Center
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.